Fabry's Disease
Also known as: Fabry / Fabry´s Disease / Fabry Disease / Fabry (-Anderson) disease / Angiokeratoma corporis diffusum universale / Deficiency of alpha-galactosidase (disorder) / Alpha galactosidase A deficiency / Fabry's disease (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB15874 | Agalsidase alfa | A recombinant human alpha-galactosidase indicated to treat Fabry disease, a genetic deficiency in the enzyme leading to buildup of globotriaosylceramide. |
DB00103 | Agalsidase beta | A recombinant human alpha-galactosidase indicated to treat Fabry disease, a genetic deficiency in the enzyme leading to buildup of globotriaosylceramide. |
DB05018 | Migalastat | An alpha-galactosidase A chaperone used for the treatment of Fabry disease in patients with an amenable galactosidase alpha gene (GLA) variant. |
DB14992 | Pegunigalsidase alfa | A recombinant form of human α-galactosidase-A indicated for long-term enzyme replacement therapy in patients with Fabry disease. |